Paula Soteropoulos
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paula Soteropoulos
Paula Soteropoulos was last confirmed as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) in a filing dated April 10, 2025. Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Paula Soteropoulos was appointed Board of Directors, effective September 11, 2023.
“In accordance with the Merger Agreement, immediately after the closing of the Merger on September 11, 2023, the size of the Board of Directors was fixed at eight members, consisting of two members designated by the Company, who are Alison F. Lawton and Anne McGeorge, and six members designated by OpCo, who are Marino Garcia, Leon O. Moulder, Jr., Tomas Kiselak, Lei Meng, Paula Soteropoulos and Jonathan Violin, Ph.D.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-01-01–2025-04-10
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.